NASDAQ: EKSO - Ekso Bionics Holdings, Inc.

छह महीने के लिए लाभप्रदता: -36.99%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Ekso Bionics Holdings, Inc.


कंपनी के बारे में

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.

अधिक जानकारी
The company also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therap, an adjustable and lower-limb powered exoskeleton; and Ekso Indego Personal, a powered lower limb orthosis. It has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in San Rafael, California.

IPO date 2014-01-16
ISIN US2826443010
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.eksobionics.com
Цена ао 1.49
प्रति दिन मूल्य परिवर्तन: +4.51% (0.621)
प्रति सप्ताह मूल्य परिवर्तन: +11.88% (0.5801)
प्रति माह मूल्य परिवर्तन: -2.26% (0.664)
3 महीने में कीमत में बदलाव: -45.92% (1.2)
छह महीने में कीमत में बदलाव: -36.99% (1.03)
प्रति वर्ष मूल्य परिवर्तन: -74.04% (2.5)
3 वर्षों में मूल्य परिवर्तन: -78.93% (3.08)
5 वर्षों में मूल्य परिवर्तन: +18.8% (0.5463)
10 वर्षों में मूल्य परिवर्तन: 0% (0.649)
वर्ष की शुरुआत से मूल्य परिवर्तन: -2.92% (0.6685)

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 1.28 9
P/BV 1.86 8
P/E 0 0
EV/EBITDA -1.64 0
कुल: 5.88

क्षमता

नाम अर्थ श्रेणी
ROA, % -52.56 0
ROE, % -120.56 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.4805 10
कुल: 10

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 31.5 5
लाभप्रदता Ebitda, % -26.27 0
लाभप्रदता EPS, % -55.08 0
कुल: 1.8

संस्थानों आयतन शेयर करना, %
Vanguard Group Inc 436925 2.44
Essex Investment Management Co LLC 157655 0.88
Kent Lake Capital, LLC 141158 0.79
Geode Capital Management, LLC 98455 0.55
Renaissance Technologies, LLC 80016 0.45
Blackrock Inc. 55453 0.31
Strategic Wealth Investment Group, LLC 51950 0.29
Compagnie Lombard Odier SCmA 25000 0.14
Northern Trust Corporation 24959 0.14
State Street Corporation 23180 0.13

ETF शेयर करना, % वर्ष के लिए लाभप्रदता, % लाभांश, %
Dimensional U.S. Core Equity 2 ETF 0 30.76 1.47098



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Scott G. Davis CEO & Director 637.02k 1970 (55 साल)
Mr. Jerome Wong Chief Financial Officer 491.39k 1974 (51 वर्ष)
Mr. Jason C. Jones Chief Operating Officer 447.42k
Ms. Rachael Anderson Global Director of Marketing & Strategic Growth N/A
Ms. Ann Cookson Human Resources Director N/A
Ms. Foon Lim Chwee President of APAC N/A
Mr. Stephan Aderhold Senior VP & GM of EMEA N/A

पता: United States, San Rafael. CA, 101 Glacier Point - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.eksobionics.com